Evidence map›Paper›PMID 19223294›Full record

ArticleThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society2009

DNA probe pooling for rapid delineation of chromosomal breakpoints.

Chun-Mei Lu, Johnson Kwan, Adolf Baumgartner, Jingly F Weier, Mei Wang, Tomas Escudero, Santiago Munné, Horst F Zitzelsberger, Heinz-Ulrich G Weier

Open access · bronzeAbstract read
In one paragraph

Article in The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Full Karyotype Interphase Cell Analysis.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2018
    Article
  3. Article
  4. Bioinformatics tools allow targeted selection of chromosome enumeration probes and aneuploidy detection.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2013
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Kinase expression and chromosomal rearrangements in papillary thyroid cancer tissues: investigations at the molecular and microscopic levels.Journal of physiology and pharmacology : an official journal of the Polish Physiological Society · 2009
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Chun-Mei LuDepartment of Chemical and Materials Engineering, National Chin-Yi University of Technology, Taiping City, Taichung, Taiwan, Republic of China.
Johnson Kwan
Adolf Baumgartner
Jingly F Weier
Mei Wang
Tomas Escudero
Santiago Munné
Horst F Zitzelsberger
Heinz-Ulrich G Weier
Lawrence Berkeley National Laboratory · USReprogenetics · USUniversity of California, San Francisco · USCalifornia Institute of Technology · USHelmholtz Zentrum München · DENational Chin-Yi University of Technology · TW

Funding

Aneuploid Cells in the Human PlacentaR01HD045736 · NICHD · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI WEIER, HEINZ-ULRICH G. · 2004 to 2006
$969k
RADIATION INDUCED THYROID CANCERR01CA080792 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI WEIER, HEINZ-ULRICH G · 2000 to 2002
$856k
Full karyotype single cell interphase analysisR44HD044313 · NICHD · REPROGENETICS, INC. · PI MUNNE, SANTIAGO · 2003 to 2005
$712k
SPECTRAL IMAGING FOR PHENOTYPE ANALYSIS OF CANCER CELLSR33CA088258 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI WEIER, HEINZ-ULRICH G · 2001 to 2002
$637k
BAC-FISH Assays for Sensitive Karyotyping of Cancer CellsR21CA123370 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI WEIER, HEINZ-ULRICH GUENTER · 2007 to 2008
$384k
SPECTRAL IMAGING FOR PHENOTYPE ANALYSIS OF CANCER CELLSR21CA088258 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI WEIER, HEINZ-ULRICH G · 2000 to 2000
$122k
NCI NIH HHS CA-123370NCI NIH HHS CA-80792NCI NIH HHS CA-88258NCI NIH HHS R21 CA123370NICHD NIH HHS HD-44313NICHD NIH HHS HD-45736NICHD NIH HHS R01 HD045736NICHD NIH HHS R44 HD044313
6 · The paper itself

Abstract

Structural chromosome aberrations are hallmarks of many human genetic diseases. The precise mapping of translocation breakpoints in tumors is important for identification of genes with altered levels of expression, prediction of tumor progression, therapy response, or length of disease-free survival, as well as the preparation of probes for detection of tumor cells in peripheral blood. Similarly, in vitro fertilization (IVF) and preimplantation genetic diagnosis (PGD) for carriers of balanced, reciprocal translocations benefit from accurate breakpoint maps in the preparation of patient-specific DNA probes followed by a selection of normal or balanced oocytes or embryos. We expedited the process of breakpoint mapping and preparation of case-specific probes by utilizing physically mapped bacterial artificial chromosome clones. Historically, breakpoint mapping is based on the definition of the smallest interval between proximal and distal probes. Thus, many of the DNA probes prepared for multiclone and multicolor mapping experiments do not generate additional information. Our pooling protocol, described here with examples from thyroid cancer research and PGD, accelerates the delineation of translocation breakpoints without sacrificing resolution. The turnaround time from clone selection to mapping results using tumor or IVF patient samples can be as short as 3 to 4 days.

Indexed as

Chromosome BreakageDNA ProbesCell LineChromosomes, Artificial, BacterialChromosomes, Human, Pair 1Chromosomes, Human, Pair 13Chromosomes, Human, Pair 4Cloning, MolecularContig MappingFemaleHumansMaleMetaphasePregnancyPreimplantation DiagnosisThyroid NeoplasmsDNA Probes

Identifiers

PMID19223294
PMCPMC2690410
OpenAlexW2170838532

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.